Clinuvel Pharmaceuticals Limited,

Clinuvel Pharmaceuticals Limited (formerly Epitan Limited) is a Melbourne based pharmaceutical company focused on dermatology.
The leading drug candidate currently in Phase II clinical trials is CUV1647 (formerly EPT1647/MelanotanTM). CUV1647 is being developed as a prophylactic photoprotective agent for two indications:

Contact Details: Level 13,1 Collins Street, Melbourne Victoria 3000 Australia Tel: 61 3 9660 4900 Fax: 61 3 9660 4999 Email: mail@clinuvel.com WWW: www.epitan.com.au/

BioNews Results for Clinuvel Pharmaceuticals Limited,:
Clinuvel Pharmaceuticals Ltd-Financial Company Report - research report released	PR inside:  Oct 30 2009 5:10PM Matching: clinuvel pharmaceuticals
Clinuvel Pharmaceuticals has $19.2m cash	Business Spectator:  Oct 28 2009 3:38AM Matching: clinuvel pharmaceuticals
Clinuvel Pharmaceuticals Ltd-Therapeutic Competitors - research report released	PR inside:  Oct 27 2009 1:39PM Matching: clinuvel pharmaceuticals

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 445 times since April 2007, the link to the organisation's website has been followed 54 times

Recent Search Terms used to find this page: Clinuvel Pharmaceuticals Limited - Detailed Product Pipeline download | .

Search for more companies in Melbourne

Search for more companies in Victoria

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Clinuvel Pharmaceuticals Limited,